126 related articles for article (PubMed ID: 38073061)
1. Fluid suppression in amide proton transfer-weighted (APTw) CEST imaging: New theoretical insights and clinical benefits.
Schüre JR; Casagranda S; Sedykh M; Liebig P; Papageorgakis C; Mancini L; Bisdas S; Nichelli L; Pinter N; Mechtler L; Jafari R; Boddaert N; Dangouloff-Ros V; Poujol J; Schmidt M; Doerfler A; Zaiss M
Magn Reson Med; 2024 Apr; 91(4):1354-1367. PubMed ID: 38073061
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study.
Zhang S; Rauch GM; Adrada BE; Boge M; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Elshafeey NA; White JB; Musall BC; Miyoshi M; Wang X; Kotrotsou A; Wei P; Hwang KP; Ma J; Pagel MD
Radiol Imaging Cancer; 2021 Sep; 3(5):e200155. PubMed ID: 34477453
[TBL] [Abstract][Full Text] [Related]
3. Generalization of quasi-steady-state reconstruction to CEST MRI with two-tiered RF saturation and gradient-echo readout-Synergistic nuclear Overhauser enhancement contribution to brain tumor amide proton transfer-weighted MRI.
Sun PZ
Magn Reson Med; 2023 May; 89(5):2014-2023. PubMed ID: 36579767
[TBL] [Abstract][Full Text] [Related]
4. Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.
Zhou J; Zaiss M; Knutsson L; Sun PZ; Ahn SS; Aime S; Bachert P; Blakeley JO; Cai K; Chappell MA; Chen M; Gochberg DF; Goerke S; Heo HY; Jiang S; Jin T; Kim SG; Laterra J; Paech D; Pagel MD; Park JE; Reddy R; Sakata A; Sartoretti-Schefer S; Sherry AD; Smith SA; Stanisz GJ; Sundgren PC; Togao O; Vandsburger M; Wen Z; Wu Y; Zhang Y; Zhu W; Zu Z; van Zijl PCM
Magn Reson Med; 2022 Aug; 88(2):546-574. PubMed ID: 35452155
[TBL] [Abstract][Full Text] [Related]
5. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
Khormi I; Al-Iedani O; Casagranda S; Papageorgakis C; Alshehri A; Lea R; Liebig P; Ramadan S; Lechner-Scott J
Magn Reson Imaging; 2023 Oct; 102():212-221. PubMed ID: 37321380
[TBL] [Abstract][Full Text] [Related]
6. Amide proton transfer weighted imaging in pediatric neuro-oncology: initial experience.
Obdeijn IV; Wiegers EC; Alic L; Plasschaert SLA; Kranendonk MEG; Hoogduin HM; Klomp DWJ; Wijnen JP; Lequin MH
NMR Biomed; 2024 Jun; 37(6):e5122. PubMed ID: 38369653
[TBL] [Abstract][Full Text] [Related]
7. The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T.
Lingl JP; Wunderlich A; Goerke S; Paech D; Ladd ME; Liebig P; Pala A; Kim SY; Braun M; Schmitz BL; Beer M; Rosskopf J
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204583
[TBL] [Abstract][Full Text] [Related]
8. Amide Proton Transfer-weighted 7-T MRI Contrast of Myelination after Cuprizone Administration.
Lee DW; Heo H; Woo DC; Kim JK; Lee DH
Radiology; 2021 May; 299(2):428-434. PubMed ID: 33724064
[TBL] [Abstract][Full Text] [Related]
9. Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla.
Chen SZ; Yuan J; Deng M; Wei J; Zhou J; Wáng YX
Eur Radiol; 2016 Jun; 26(6):1792-800. PubMed ID: 26334509
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the molecular origin of amide proton transfer-weighted imaging.
Sun C; Zhao Y; Zu Z
Magn Reson Med; 2024 Feb; 91(2):716-734. PubMed ID: 37749854
[TBL] [Abstract][Full Text] [Related]
11. Amide Proton Transfer (APT) MR imaging and Magnetization Transfer (MT) MR imaging of pediatric brain development.
Zhang H; Kang H; Zhao X; Jiang S; Zhang Y; Zhou J; Peng Y
Eur Radiol; 2016 Oct; 26(10):3368-76. PubMed ID: 26762941
[TBL] [Abstract][Full Text] [Related]
12. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
[TBL] [Abstract][Full Text] [Related]
13. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
[TBL] [Abstract][Full Text] [Related]
14. Repeatability of amide proton transfer-weighted signals in the brain according to clinical condition and anatomical location.
Lee JB; Park JE; Jung SC; Jo Y; Kim D; Kim HS; Choi CG; Kim SJ; Kang DW
Eur Radiol; 2020 Jan; 30(1):346-356. PubMed ID: 31338651
[TBL] [Abstract][Full Text] [Related]
15. Snapshot CEST++: Advancing rapid whole-brain APTw-CEST MRI at 3 T.
Sedykh M; Liebig P; Herz K; Fabian MS; Mennecke A; Weinmüller S; Schmidt M; Dörfler A; Zaiss M
NMR Biomed; 2023 Oct; 36(10):e4955. PubMed ID: 37076984
[TBL] [Abstract][Full Text] [Related]
16. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
[TBL] [Abstract][Full Text] [Related]
17. Improved chemical exchange saturation transfer imaging with real-time frequency drift correction.
Liu R; Zhang H; Niu W; Lai C; Ding Q; Chen W; Liang S; Zhou J; Wu D; Zhang Y
Magn Reson Med; 2019 May; 81(5):2915-2923. PubMed ID: 30697813
[TBL] [Abstract][Full Text] [Related]
18. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
[TBL] [Abstract][Full Text] [Related]
19. Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T.
By S; Barry RL; Smith AK; Lyttle BD; Box BA; Bagnato FR; Pawate S; Smith SA
Magn Reson Med; 2018 Feb; 79(2):806-814. PubMed ID: 28474409
[TBL] [Abstract][Full Text] [Related]
20. Enhancing sensitivity of pH-weighted MRI with combination of amide and guanidyl CEST.
Jin T; Wang P; Hitchens TK; Kim SG
Neuroimage; 2017 Aug; 157():341-350. PubMed ID: 28602944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
